Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.51
+0.09 (0.96%)
At close: May 11, 2026, 4:00 PM EDT
9.59
+0.08 (0.79%)
After-hours: May 11, 2026, 7:55 PM EDT
Kura Oncology Employees
Kura Oncology had 260 employees as of December 31, 2025. The number of employees increased by 68 or 35.42% compared to the previous year.
Employees
260
Change (1Y)
68
Growth (1Y)
35.42%
Revenue / Employee
$259,546
Profits / Employee
-$1,071,792
Market Cap
844.13M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| ARS Pharmaceuticals | 163 |
| Alpha Tau Medical | 121 |
| Aura Biosciences | 113 |
| Janux Therapeutics | 109 |
| Theravance Biopharma | 90 |
| CytomX Therapeutics | 69 |
| Alto Neuroscience | 68 |
KURA News
- 5 days ago - Kura Oncology to Participate in Bank of America Securities Healthcare Conference - GlobeNewsWire
- 6 days ago - Kura Oncology to Report First Quarter 2026 Financial Results - GlobeNewsWire
- 7 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML - GlobeNewsWire
- 24 days ago - Kura Oncology Transcript: Investor Update - Transcripts
- 24 days ago - Kura Oncology reports results from ongoing FIT-001 clinical trial - TheFly
- 24 days ago - Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib - GlobeNewsWire
- 27 days ago - Kura Oncology initiated with a Buy at Lake Street - TheFly